Theophylline derivative inhibits osteoporosis
US8507506B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2011 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Jul 10, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The theophylline derivative disclosed in the present invention is characterized by having the pharmaceutical functions of osteoporosis. The theophylline derivative protects against bone resorption and inflammatory mediator infiltration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.